Brazil vs South Africa: Treatment success rate for patients treated for MDR-TB
Brazil
60.0%
in 2022
South Africa
63.0%
in 2022
Brazil rank
120th
South Africa rank
118th
Treatment success rate for patients treated for MDR-TB over time
- Brazil
- South Africa
How they compare
South Africa currently reports 63.0% against 60.0% in Brazil, a difference of 3.0%.
That makes South Africa's figure about 1.1 times Brazil's.
The two have swapped places 3 times across 17 shared years of data; in 2002 it was Brazil ahead.
Brazil ranks 120th and South Africa ranks 118th of 163 countries.
Across the 3 decades both report, Brazil averaged higher in 2 and South Africa in 1.
Head to head by decade
| Decade | Brazil | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 45.2% | 4.8% | Brazil |
| 2010s | 56.8% | 53.6% | 3.2% | Brazil |
| 2020s | 55.3% | 62.3% | 7.0% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Brazil or South Africa?
- South Africa, at 63.0% against 60.0% in Brazil as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Brazil and South Africa?
- 3.0%, with South Africa ahead.
- How many years of comparable data are there for Brazil and South Africa?
- 17 years are reported by both, from 2002 to 2022.
- How do Brazil and South Africa rank globally for treatment success rate for patients treated for mdr-tb?
- Brazil ranks 120th and South Africa ranks 118th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.